Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Altus Pharmaceuticals Inc. (ALTU) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $9.87 Metrics
OS: 31.1 M -1141 % ROE
Market cap: $307 M -915 % ROIC
Net cash: $8.05 M $0.26 per share
EV: $299 M

 
TTM Valuation
EBITDA ($70.6) M
EBIT ($73.2) M
EPS ($4.66)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
Revenues2.228.55.18.34.23.92.4
            Revenue growth-92.4%457.8%-38.4%95.9%9.0%63.9% 
Cost of goods sold0.00.00.00.00.31.80.7
Gross profit2.228.55.18.34.02.01.6
            Gross margin100.0%100.0%100.0%100.0%93.6%52.4%69.4%
Selling, general and administrative0.00.00.00.025.217.519.6
EBIT-99.2-67.7-60.0-27.1-21.3-15.5-17.9
            EBIT margin-4589.4%-237.8%-1175.0%-326.6%-502.9%-399.7%-756.2%
Pre-tax income-96.6-63.2-55.7-27.1-21.0-15.2-17.3
Income taxes0.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-0.1-0.1-0.10.00.00.00.0
            Net margin-4.5%-0.2%-1.1%-0.5%-0.7%-0.5%-0.9%
 
Diluted EPS($3.13)($2.23)($2.75)($22.12)($17.34)($11.91)($13.16)
Shares outstanding (diluted)0.00.00.00.00.00.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy